Cartesian therapeutics director Timothy Springer buys $4.29m in stock
In a recent series of transactions, Timothy A. Springer, a director and ten percent owner of Cartesian Therapeutics, Inc. (NASDAQ:RNAC), made significant stock purchases totaling approximately $4.29 million. The acquisitions, conducted over a series of …